Ronald Cooper
Chief Executive Officer at ALBIREO PHARMA, INC.
Net worth: 38 665 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jan Peter Mattsson | M | 60 |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom.
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 21 years |
| Christopher Boerner | M | 53 | 9 years | |
| Mike Gutch | M | 58 |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom.
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 9 years |
| Phil Holzer | M | 48 | 11 years | |
| David Chiswell | M | 70 |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom.
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 17 years |
| Davey Scoon | M | 78 |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 11 years |
| Roger Jeffs | M | 62 |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 6 years |
| Jason Rhodes | M | 54 | 8 years | |
| Cameron McDonough | M | 53 | 7 years | |
| Anne Klibanski | M | 73 |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 5 years |
| Alan Sokaler | M | - | - | |
| Louis Schmukler | M | - | 13 years | |
| Yalonda Howze | F | 52 | 1 years | |
| Maren Killackey | F | - | - | |
| Catherine Stehman-Breen | M | 61 | 7 years | |
| Donald Nicholson | M | 67 | 7 years | |
| Antoinette Paone | F | 46 | 6 years | |
| Jeff Jonas | M | 71 | 6 years | |
| Matthew Norkunas | M | 46 | 4 years | |
| Charles Rowland | M | 65 | 6 years | |
| Anthony Quinn | M | 62 | 7 years | |
| Gustav Christensen | M | 76 | 7 years | |
| Per-Göran Gillberg | M | 68 |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | 26 years |
| Muffy Carter | F | 71 | 8 years | |
| Christelle Huguet | M | 57 | 1 years | |
| Zack Newman | M | - | 11 years | |
| Dannielle Appelhans | F | 41 | 2 years | |
| Joan Connolly | F | - | 3 years | |
| Colleen Alabiso | F | - | - | |
| Matthew Stanton | M | 51 | 7 years | |
| Jennifer Benenson | F | - | 1 years | |
| Girish Aakalu | M | - | 6 years | |
| Paul Streck | M | 60 | 2 years | |
| Aymeric Le Chatelier | M | 55 | 1 years | |
| Heather White | F | - | 1 years | |
| François-Maurice Garnier | M | 62 | 1 years | |
| Michelle Graham | F | 57 | 5 years | |
| Phillip Samayoa | M | 37 | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas A. Shea | M | 64 |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | - |
| James Cornelius | M | 81 | 10 years | |
| John E. Celentano | M | 64 | 31 years | |
| Kevin Bitterman | M | 47 | 11 years | |
| Jonathan Michael Poole | M | 49 | 4 years | |
| Thomas Lynch | M | 63 | 5 years | |
| Michael Alfieri | M | 59 | - | |
| Jason Haddock | M | 54 | 14 years | |
| Habib Dable | M | 54 | 1 years | |
| Carl Decicco | M | 62 | 10 years | |
| Kristina Torfgård | M | 61 | 2 years | |
| Howard Mayer | M | 62 | 3 years | |
| Peter A. Zorn | M | 53 | 3 years | |
| Jason G. Duncan | M | 50 | - | |
| Douglas Kerr | M | 57 | 5 years | |
| Stephanie Okey | F | 64 | 5 years | |
| Togo Dennis West | M | 81 | 10 years | |
| Simon Harford | M | 64 | - | |
| Sara Den Besten | F | - | - | |
| Brian Daniels | M | 65 | 14 years | |
| Jacquelyn Sumer | F | 46 | - | |
| Julia Brown | F | 76 | 2 years | |
| Ali Behbahani | M | 47 | 4 years | |
| Heather Elizabeth Preston | M | 58 | 10 years | |
| James Robinson | M | 88 | 29 years | |
| Charles Sigal | M | 72 | 16 years | |
| Anthony Hooper | M | 69 | 15 years | |
| Louis J. Freeh | M | 74 | 8 years | |
| Dinesh C. Paliwal | M | 67 | 8 years | |
| Robert Williams | M | 75 | 7 years | |
| Denise Scots-Knight | M | 64 | 9 years | |
| Béatrice J. Cazala | F | 67 | 32 years | |
| Susan Alesina | F | 61 | 1 years | |
| Stephen J. Hoffman | M | 70 | 7 years | |
| Alan J. Lacy | M | 70 | 12 years | |
| Gisela Schwab | M | 67 | 1 years | |
| Gerald Storch | M | 67 | 12 years | |
| Leif Valdemar Johansson | M | 73 | 13 years | |
| Kelly Schick | F | 44 | - | |
| Randall Owen | M | - | 6 years | |
| Edward Berg | M | - | 2 years | |
| Rebecca Drain | F | 61 | 3 years | |
| Lynn Sadowski Mason | F | 45 | 2 years | |
| Stephen E. Bear | M | 73 | 7 years | |
| John Shamsey | M | - | 6 years | |
| Kevin Trapp | M | - | 2 years | |
| Wendy Dixon | M | 68 | 8 years | |
| Karen Murphy Santiago | F | 53 | 10 years | |
| Frances K. Heller | F | 57 | - | |
| David Ian Johnson | M | 66 | 12 years | |
| Katrin Rupalla | M | 56 | 7 years | |
| Freda Lewis-Hall | M | 69 | 5 years | |
| Elliott Levy | M | 64 | 17 years | |
| Xiaolin Liu | M | - | 2 years | |
| Ann Powell | F | 58 | 10 years | |
| Linda Jordan | F | - | - | |
| Lynn H. Clark | F | 66 | 8 years | |
| Cheryl Capps | F | 62 | 13 years | |
| Robert G. Petit | M | 64 | 5 years | |
| Michael Burgess | M | 61 | - | |
| Holly Tyson | F | 52 | 8 years | |
| Kyu-Sung Lee | M | 64 | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 99.00% |
| Sweden | 7 | 7.00% |
| United Kingdom | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronald Cooper
- Personal Network